Tarsadia
Tarsadia is a multi-dimensional investment firm that focuses on making high conviction investments in category-defining companies. With a mission to make tomorrow better than today, Tarsadia has a long history of success across various asset classes, driving billions of dollars in value creation. The firm operates with a permanent capital base and a best-in-class investment structure, allowing it to work across both private and public markets. Tarsadia is committed to being a differentiated capital partner, uniquely aligned with its portfolio companies and their founders.
Tarsadia
520 Newport Center Dr, 21st Floor, Newport Beach, CA 92660
Portfolio
Amneal is a fully integrated global essential medicines company with a diverse portfolio of approximately 270 generic and specialty pharmaceuticals.
#Pharmaceuticals
AvantStay is a platform for kitting out and renting high-end vacation rental homes. It raised $160 million in a Series B round, with Tarsadia Investments as a co-lead investor.
#Travel and Hospitality
bolttech is an international insurtech company that raised $210 million in its Series A funding round to accelerate international expansion.
#Insurtech
Cambridge Mobile Telematics is a leader in mobile telematics and analytics, providing services to 21 out of the 25 largest auto insurers in the U.S.
#Telematics
Kirilys is a preclinical-stage biopharmaceutical company focused on precision oncology, with its lead compound KRLS-017 licensed from Ube Industries, Ltd.
#Biopharmaceuticals
Chronus Health is a point-of-care diagnostics company that raised $22 million in a Series A financing round to scale its research, engineering, and data science teams, and accelerate its product and technology development.
#Healthcare Technology
Cue Health is a healthcare technology company that closed a $235 million private financing round to accelerate its growth and digital transformation of healthcare, beginning with diagnostics.
#Health Technology
Envisics is a UK-based holographic technology startup that raised $50 million in a Series B round to develop in-car holographic display technology.
#Automotive Technology
Kashiv is a fully integrated biopharmaceutical company developing advanced-stage biosimilars and specialty biopharmaceutical products. It has received multiple FDA approvals for its biosimilar products.
#Biopharmaceuticals